VU0119498,99.52%

产品编号:Bellancom-114933| CAS NO:79183-37-2| 分子式:C15H10BrNO2| 分子量:316.15

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-114933
600.00 杭州 北京(现货)
Bellancom-114933
1100.00 杭州 北京(现货)
Bellancom-114933
1600.00 杭州 北京(现货)
Bellancom-114933
2400.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

VU0119498

产品介绍 VU0119498 是一种泛 Gq mAChR M1,M3,M5 的正变构调节剂 (PAM),EC50 值分别为 6.04,6.38 和 4.08 µM。VU0119498 具有抗糖尿病活性。
生物活性

VU0119498 is a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM), with EC50s of 6.04, 6.38, and 4.08 µM, respectively. VU0119498 has antidiabetic activity.

体外研究

VU0119498 (0.01-30 μM; 150 s) potentiates Ach responses in M1, M3, and M5-expressing CHO cells, with EC50s of 6.04, 6.38, and 4.08 µM, respectively.
VU0119498 (3-20 μM) augments ACh-mediated increasing in insulin secretion and intracellular calcium levels in MIN6-K8 cells.
VU0119498 (20 μM; 90 min) enhances ACh-induced insulin release in mouse and human pancreatic islets.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

VU0119498 (0.1-2 mg/kg; a single i.p.) improves glucose tolerance and insulin secretion in mice in a β-cell M3R-dependent fashion.
VU0119498 (0.5 mg/kg; a single i.p.) improves glucose tolerance and insulin secretion in obese, glucose-intolerant mice.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male WT mice (12 weeks)
Dosage: 0.1, 0.5, 2 mg/kg
Administration: A single i.p.
Result: Caused a significant improvement in glucose tolerance at the dose of 0.5 mg/kg.
Significantly augmented GSIS at the dose of 0.5 mg/kg.
体内研究

VU0119498 (0.1-2 mg/kg; a single i.p.) improves glucose tolerance and insulin secretion in mice in a β-cell M3R-dependent fashion.
VU0119498 (0.5 mg/kg; a single i.p.) improves glucose tolerance and insulin secretion in obese, glucose-intolerant mice.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male WT mice (12 weeks)
Dosage: 0.1, 0.5, 2 mg/kg
Administration: A single i.p.
Result: Caused a significant improvement in glucose tolerance at the dose of 0.5 mg/kg.
Significantly augmented GSIS at the dose of 0.5 mg/kg.
性状Solid
溶解性数据
In Vitro: 

DMSO : 50 mg/mL (158.15 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.1631 mL 15.8153 mL 31.6306 mL
5 mM 0.6326 mL 3.1631 mL 6.3261 mL
10 mM 0.3163 mL 1.5815 mL 3.1631 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服